Is clampdown on Swiss stem cell therapies justified? - 1. Mai 2016 - VISCHER

Close

Wonach suchen Sie?

Kesselring Felix/Kohler Stefan, Is clampdown on Swiss stem cell therapies justified?, in: China Business Law Journal Volume 7 Issue 4, April 2016, S. 78 f.

Autor:

Stefan Kohler

Kategorien: Gesundheitswesen, Life Sciences, Pharma, Biotechnologie, Public Sector und Regulatory, Publikationen & Präsentationen

You are currently offline. Some pages or content may fail to load.